If diarrhea is severe or persistent, seek medical advice
The TRIUMPH program includes studies examining weight loss outcomes, cardiovascular endpoints, and comorbidity improvements like osteoarthritis pain relief
Here are a few ways theyre similar
Sources Comparative review of semaglutide and tirzepatide mechanisms (Pharmacological Research, ScienceDirect) A Contemporary Rationale for Agonism of the GIP Receptor in the Treatment of Obesity (Diabetes, American Diabetes Association) GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models (PMC) Anorectic and aversive effects of GLP-1 receptor agonism mediated by brainstem CCK neurons, modulated by GIP (PMC) Head-to-Head Trial Compares Weight Loss Drugs (Weill Cornell Medicine Newsroom, reporting NEJM SURMOUNT-5) Head-to-head comparison of tirzepatide and semaglutide for weight loss: systematic review and meta-analysis (PubMed) Are You a GLP-1 Nonresponder
If a person is allergic, a painful rash may form on the skin
The most important practical distinction is pathway: CJC-1295 / Sermorelin / Tesamorelin: GHRH receptor pathway Ipamorelin / GHRP-2 / GHRP-6 / Hexarelin / MK-677: ghrelin or GHSR pathway HGH / GH: direct hormone, not a secretagogue This is why CJC-1295 and Ipamorelin are often studied together: they represent complementary upstream signals into GH-axis biology
